# Pharmacokinetics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade in Patients During Laparoscopic Surgery

> **NCT05328778** · PHASE4 · COMPLETED · sponsor: **Guangzhou General Hospital of Guangzhou Military Command** · enrollment: 48 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Sugammadex

## Key facts

- **NCT ID:** NCT05328778
- **Lead sponsor:** Guangzhou General Hospital of Guangzhou Military Command
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-14
- **Primary completion:** 2025-01-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2026-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05328778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05328778, "Pharmacokinetics of Sugammadex in Reversal of Vecuronium-induced Neuromuscular Blockade in Patients During Laparoscopic Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05328778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*